Sunday, 27 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Apollo Hospitals Enterprise Investor Presentation: Key Takeaways

Apollo Hospitals reported strong Q1FY27 consolidated revenue growth of 21% YoY to ₹70,435 mio, driven by robust healthcare services and diagnostics performance alongside narrowing digital cash losses.

Guidance and delivery
Management target Revenue Q4FY27
Highlights
Revenue growth21% YoY consolidated growth.
MarginsEBITDA margin improved 90bps YoY to 15.5%.
Demand visibilityStrong; 13% growth in inpatient volumes.
Management confidenceHigh; focusing on omnichannel leadership and bed expansion.

Growth

Consolidated PAT grew 34% YoY to ₹5,805 mio; EBITDA rose 28% to ₹10,920 mio with 15.5% margin.

Outlook

Targeting 14,100 total census beds post-expansion; Q4FY27 revenue run-rate guided at INR 250bn with 6.5-7.0% EBITDA margin.

Risks

Expansion costs for 5 new hospitals impacting margins; regulatory approval pending for Keimed/Cloudnine mergers.

Source

Investor Presentation filed with NSE, NSE: APOLLOHOSP. Summary written with AI assistance from the document.

Read the document ↗

Apollo Hospitals Enterprise Ltd: key numbers

Share price
₹8,889.00
Market cap
₹1,27,810 Cr
Revenue (annual)
₹25,228 Cr
Net profit (annual)
₹1,942 Cr
P/E (TTM)
61.2×Sector 57.8×
Promoter holding
28.02%+0.00% QoQ
FII holding
41.49%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Apollo Hospitals Enterprise Ltd

All →